GPR142 Controls Tryptophan-Induced Insulin and Incretin Hormone Secretion to Improve Glucose Metabolism

• Hua V. Lin ,

  * E-mail: lin_hua@lilly.com

  Affiliation Lilly China Research and Development Center (LCRDC), Eli Lilly & Company, Shanghai, China

  http://orcid.org/0000-0001-5001-5567

  ⨯
• Alexander M. Efanov,

  Affiliation Lilly Research Laboratories, Lilly Corporate Center, Eli Lilly & Company, Indianapolis, Indiana, United States of America

  ⨯
• Xiankang Fang,

  Affiliation Lilly China Research and Development Center (LCRDC), Eli Lilly & Company, Shanghai, China

  ⨯
• Lisa S. Beavers,

  Affiliation Lilly Research Laboratories, Lilly Corporate Center, Eli Lilly & Company, Indianapolis, Indiana, United States of America

  ⨯
• Xuesong Wang,

  Affiliation Lilly China Research and Development Center (LCRDC), Eli Lilly & Company, Shanghai, China

  ⨯
• Jingru Wang,

  Affiliation Lilly China Research and Development Center (LCRDC), Eli Lilly & Company, Shanghai, China

  ⨯
• Isabel C. Gonzalez Valcarcel,

  Affiliation Lilly Research Laboratories, Lilly Corporate Center, Eli Lilly & Company, Indianapolis, Indiana, United States of America

  ⨯
• Tianwei Ma

  Affiliation Lilly China Research and Development Center (LCRDC), Eli Lilly & Company, Shanghai, China

  ⨯